CardiologyDr. Z S MeharwalCardiac Surgery

Chairman & Head - Adult Cardiac Surgery, Fortis Escorts, New Delhi, India

Part 2 of 16 in Advances in Cardiac Surgeries

Anticoagulation After Mechanical Heart Valve Replacement: Risks and Management

August 5, 2026

Every patient who receives a mechanical heart valve needs lifelong anticoagulation with a vitamin K antagonist such as warfarin or acitrom to prevent dangerous blood clots forming on the valve. This requirement is one of two major trade-offs patients weigh when choosing a heart valve, the other being the risk of a tissue valve wearing out over time.

Why anticoagulation is required after mechanical valve replacement

Mechanical heart valves, used to treat valvular heart disease, are made of durable materials that do not degenerate the way biological tissue valves do, but blood tends to clot when it comes into contact with these artificial surfaces. Vitamin K antagonist anticoagulation prevents this clotting and protects the valve from thrombosis and thromboembolism, in which a clot breaks loose and travels through the bloodstream.

The risks of lifelong anticoagulation

Anticoagulation carries its own risks, principally bleeding, alongside the risks of valve thrombosis and thromboembolism it is meant to prevent. Patients must monitor their International Normalised Ratio, or INR, regularly and report to a valve clinic or hospital so their anticoagulant dose can be adjusted. This monitoring requirement was one of the main reasons tissue valves were developed in the 1970s and 1980s, to give patients with valvular heart disease an alternative that does not require lifelong anticoagulation.

How age and pregnancy plans affect the anticoagulation decision

Guidelines from the American College of Cardiology and American Heart Association, the European Society of Cardiology, and the Indian Association of Cardiovascular and Thoracic Surgery all agree that valve choice should be based on the informed patient's preference, provided there is no contraindication to anticoagulants and the therapy can be managed appropriately. Mechanical valves are generally preferred for patients in their 50s and 60s, since they last longer and anticoagulation is easier to manage at a younger age. Tissue valves are preferred for women who want to become pregnant, regardless of age, because anticoagulants used with mechanical valves carry risks to both mother and foetus. Dr. Z. S. Meharwal, Chairman and Head of Adult Cardiac Surgery at Fortis Escorts Heart Institute, New Delhi, discusses these anticoagulation trade-offs with every patient before valvular heart disease surgery, including African patients travelling to India for heart valve surgery.

← Mechanical Heart Valves: History, Types and What Patients Should Know | Series index | Home INR Monitoring After Heart Valve Surgery: Is It Better Than Hospital Visits? →

This article is based on a Jivo Masterclass session conducted by Dr. Z. S. Meharwal, Chairman and Head, Adult Cardiac Surgery, Fortis Escorts Heart Institute, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

This guide is based on a live Jivo Masterclass — Dr. Z S Meharwal taught doctors across Africa on October 26, 2025.

FROM THE LIVE Q&A

HO

Host (Varun, Jivo Healthcare)

What is the most common dilemma doctors practising in resource-constrained environments like Africa face: how do they decide whether a case should be handled locally or referred across the border for specialist intervention?

ZS

Dr. Z S Meharwal

The patient should be referred for further evaluation at the appropriate time — not too early, but also not too late, because if it is too late the patient develops more comorbidities and the outcome may not be as good. For valve disease specifically, there are definite guidelines for mitral and aortic valve disease on when a patient should be referred for cardiac surgery; whether it can be done locally depends on whether it looks like a straightforward repair or replacement, or a more challenging one. The two important criteria are the patient's clinical symptoms — which functional class (1, 2, 3, or 4) — and the echo findings, which show the severity of stenosis or regurgitation, LV function, and pulmonary artery pressures. Together these decide whether the patient should be referred for surgical treatment, locally or elsewhere.

See all 6 questions from this masterclass →

Book a Consultation with Dr. Z S Meharwal

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

What is the financial implication of these surgeries, whether mechanical or tissue-based valve replacement?

Cost primarily depends on two things: which valve is used — mechanical valves are significantly less expensive than tissue valves, and among tissue valves, third-generation valves cost more than second-generation ones — and the patient's clinical course, since a straightforward surgery without a long hospital stay or comorbidities costs less. The average cost generally starts from $9,000 and goes up to $15,000–$16,000.

For a child born with a non-obstructing mass over the apical side of the heart, around 1.4 cm by 1 cm, with no sign of heart failure — the baby is now 3 months old, echo is otherwise normal except for the mass, which is likely a rhabdomyoma on differential, and has shown some decrease in size (from 1.4x1 cm to 1.2x0 cm over a month) — should we consider surgical management, or when should surgical management be considered?

Cardiac tumours in children are well known, though this exact pathology is not very common. The echo gives us an idea, but I would suggest also doing an MRI and a CT to further delineate it. I would like the details of this patient sent to our institute so we can forward it to our paediatric cardiac surgeon, since paediatric cardiac surgery is a separate subspecialty from the adult cardiac surgery I practise, and we do have a dedicated paediatric cardiac surgical team. This child needs very close follow-up and further investigation.

For a tetralogy of Fallot patient where surgery was not done at an early age and the patient is now around 6 years old, what is the survival rate if surgery is not done, and what is the success rate of surgery done now?

Tetralogy of Fallot is one of the commonest surgical procedures, and the outcome depends on the exact anatomy delineated by a proper paediatric echo, but six years is not a very late stage — in India a lot of patients are operated on at this age or even older. The outcome of tetralogy repair even at 6 years is excellent, so this patient certainly needs surgical correction.

An adult patient with myocardial bridging is on a beta blocker — should surgery be done, and if surgery is not done, what are the possible negative complications?

Myocardial bridging is not uncommon and is often seen on angiography. If it is asymptomatic, nothing needs to be done. If it is symptomatic, we normally do a stress thallium test — if positive, we recommend surgery; if negative, which is most of the time, only medical treatment is needed. If it is only myocardial bridging with no stenosis involved in other arteries (the circumflex or right coronary artery are normal), nothing needs to be done, but if the stress test is positive, surgery is recommended.

What is the place of surgery in children with tetralogy of Fallot?

Tetralogy of Fallot is one of the commonest procedures in paediatric cardiac surgery, alongside ASD and VSD repair. It is a very commonly performed procedure with excellent outcomes — any paediatric cardiac centre does this routinely, and the clinical outcomes are excellent.

Why do mechanical heart valve patients need lifelong anticoagulation?

Mechanical heart valves are made of durable materials that do not degenerate like biological tissue, but blood tends to clot when it contacts these artificial surfaces. Lifelong anticoagulation with a vitamin K antagonist such as warfarin or acitrom prevents this clotting and protects the valve from thrombosis and thromboembolism.

What are the risks of lifelong anticoagulation after valve replacement?

The main risk is bleeding, alongside the valve thrombosis and thromboembolism the anticoagulation is meant to prevent. Patients must also monitor their International Normalised Ratio regularly and report to a valve clinic or hospital so their dose can be adjusted.

At what age is a mechanical valve generally preferred over a tissue valve?

Mechanical valves are generally preferred for patients in their 50s and 60s, since they last longer and anticoagulation is easier to manage at a younger age.

Why are tissue valves recommended for women who want to become pregnant?

Tissue valves are preferred for women who want to become pregnant, regardless of age, because the anticoagulants used with mechanical valves carry risks to both mother and foetus.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion